CN101269113A - 一种治疗肿瘤的药物组合物的质量控制方法 - Google Patents
一种治疗肿瘤的药物组合物的质量控制方法 Download PDFInfo
- Publication number
- CN101269113A CN101269113A CNA2008100972900A CN200810097290A CN101269113A CN 101269113 A CN101269113 A CN 101269113A CN A2008100972900 A CNA2008100972900 A CN A2008100972900A CN 200810097290 A CN200810097290 A CN 200810097290A CN 101269113 A CN101269113 A CN 101269113A
- Authority
- CN
- China
- Prior art keywords
- peak
- volume
- parts
- peaks
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 238000003908 quality control method Methods 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 211
- 238000012360 testing method Methods 0.000 claims abstract description 203
- 241000208340 Araliaceae Species 0.000 claims abstract description 68
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 67
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 67
- 235000008434 ginseng Nutrition 0.000 claims abstract description 67
- 238000000034 method Methods 0.000 claims abstract description 50
- 239000000945 filler Substances 0.000 claims abstract description 49
- 229940079593 drug Drugs 0.000 claims abstract description 34
- 239000000047 product Substances 0.000 claims abstract description 32
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 claims abstract description 29
- 229930015582 oxymatrine Natural products 0.000 claims abstract description 29
- 239000000243 solution Substances 0.000 claims description 327
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 324
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 164
- 239000007788 liquid Substances 0.000 claims description 131
- 239000013558 reference substance Substances 0.000 claims description 122
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 116
- 238000007639 printing Methods 0.000 claims description 107
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 107
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 104
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 100
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 91
- 239000000890 drug combination Substances 0.000 claims description 91
- 230000014759 maintenance of location Effects 0.000 claims description 72
- 239000000523 sample Substances 0.000 claims description 67
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 60
- 238000005303 weighing Methods 0.000 claims description 55
- 239000009636 Huang Qi Substances 0.000 claims description 54
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 54
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 claims description 50
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 48
- 239000000377 silicon dioxide Substances 0.000 claims description 48
- 238000011003 system suitability test Methods 0.000 claims description 45
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 claims description 43
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 claims description 43
- LTTQKYMNTNISSZ-MWTRTKDXSA-N (2S)-(-)-kurarinone Chemical compound C1([C@H]2OC=3C(C[C@@H](CC=C(C)C)C(C)=C)=C(O)C=C(C=3C(=O)C2)OC)=CC=C(O)C=C1O LTTQKYMNTNISSZ-MWTRTKDXSA-N 0.000 claims description 38
- XQVFLLMCNGKXSM-UHFFFAOYSA-N kurarinone Natural products COc1cc(O)c(C(CC=C(C)C)C(=C)C)c2OC(CC(=O)c12)c3ccc(O)cc3O XQVFLLMCNGKXSM-UHFFFAOYSA-N 0.000 claims description 38
- KDADHLPROOOPIC-UHFFFAOYSA-N neokurarinol Natural products COc1cc(O)ccc1C1CC(=O)c2c(OC)cc(O)c(CC(CCC(C)(C)O)C(C)=C)c2O1 KDADHLPROOOPIC-UHFFFAOYSA-N 0.000 claims description 38
- 238000012546 transfer Methods 0.000 claims description 38
- 239000012088 reference solution Substances 0.000 claims description 37
- 239000006228 supernatant Substances 0.000 claims description 34
- 239000000706 filtrate Substances 0.000 claims description 32
- 238000001514 detection method Methods 0.000 claims description 29
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 28
- 239000000543 intermediate Substances 0.000 claims description 28
- 238000010992 reflux Methods 0.000 claims description 28
- 238000010828 elution Methods 0.000 claims description 26
- 229930182494 ginsenoside Natural products 0.000 claims description 26
- 229940089161 ginsenoside Drugs 0.000 claims description 26
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 claims description 24
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 24
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 claims description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 21
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 claims description 21
- 238000003556 assay Methods 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 19
- 238000005374 membrane filtration Methods 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 17
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 claims description 16
- 239000000796 flavoring agent Substances 0.000 claims description 16
- 235000019634 flavors Nutrition 0.000 claims description 16
- 238000002347 injection Methods 0.000 claims description 16
- 239000007924 injection Substances 0.000 claims description 16
- 239000012567 medical material Substances 0.000 claims description 16
- 238000004321 preservation Methods 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 14
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 241001061264 Astragalus Species 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 8
- 235000006533 astragalus Nutrition 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 239000003610 charcoal Substances 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 8
- 238000004064 recycling Methods 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 claims description 7
- YEZWWUMWIFKEQM-UHFFFAOYSA-N O.OC.ClC(Cl)Cl.CCOC(C)=O Chemical compound O.OC.ClC(Cl)Cl.CCOC(C)=O YEZWWUMWIFKEQM-UHFFFAOYSA-N 0.000 claims description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 7
- 238000000105 evaporative light scattering detection Methods 0.000 claims description 7
- 238000010812 external standard method Methods 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 239000000741 silica gel Substances 0.000 claims description 7
- 229910002027 silica gel Inorganic materials 0.000 claims description 7
- 238000004809 thin layer chromatography Methods 0.000 claims description 7
- -1 reflux Substances 0.000 claims description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 2
- 238000004811 liquid chromatography Methods 0.000 claims 12
- 238000012850 discrimination method Methods 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 6
- 150000001875 compounds Chemical class 0.000 abstract 5
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000013067 intermediate product Substances 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 description 16
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 238000013112 stability test Methods 0.000 description 8
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 6
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 description 6
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003182 parenteral nutrition solution Substances 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- NYGZYUAVZPIKBZ-BDJLRTHQSA-N Kushenin Natural products O(C)c1c(O)cc2O[C@H]3[C@@H](c2c1)COc1c3ccc(O)c1 NYGZYUAVZPIKBZ-BDJLRTHQSA-N 0.000 description 2
- NYGZYUAVZPIKBZ-UHFFFAOYSA-N Lespedezol D1 Natural products C1OC2=CC(O)=CC=C2C2C1C(C=C(C(=C1)O)OC)=C1O2 NYGZYUAVZPIKBZ-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- NYGZYUAVZPIKBZ-ZBEGNZNMSA-N lespedezol D1 Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C(C=C(C(=C1)O)OC)=C1O2 NYGZYUAVZPIKBZ-ZBEGNZNMSA-N 0.000 description 2
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810097290A CN101269113B (zh) | 2008-05-09 | 2008-05-09 | 一种治疗肿瘤的药物组合物的质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810097290A CN101269113B (zh) | 2008-05-09 | 2008-05-09 | 一种治疗肿瘤的药物组合物的质量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101269113A true CN101269113A (zh) | 2008-09-24 |
CN101269113B CN101269113B (zh) | 2012-08-29 |
Family
ID=40003504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810097290A Active CN101269113B (zh) | 2008-05-09 | 2008-05-09 | 一种治疗肿瘤的药物组合物的质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101269113B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101849630A (zh) * | 2010-06-25 | 2010-10-06 | 延边大学 | 黄芪保健食品及其制备方法 |
CN103105371A (zh) * | 2011-11-10 | 2013-05-15 | 长白山制药股份有限公司 | 一种药物组合物注射液的质量检测方法 |
CN103575667A (zh) * | 2012-07-24 | 2014-02-12 | 长白山制药股份有限公司 | 一种药物组合物注射液总皂苷的含量测定方法 |
CN103977060A (zh) * | 2014-05-16 | 2014-08-13 | 长白山制药股份有限公司 | 一种抗肿瘤药物组合物及其制备方法 |
CN107625894A (zh) * | 2017-10-12 | 2018-01-26 | 吉林化工学院 | 一种复方参芪分散片的制备方法 |
CN111686148A (zh) * | 2019-11-06 | 2020-09-22 | 成都青之欣生物科技有限公司 | 抗衰老的中药提取物及其提取方法和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100437109C (zh) * | 2005-08-16 | 2008-11-26 | 李彦群 | 一种治疗肿瘤的注射液的质量控制方法 |
-
2008
- 2008-05-09 CN CN200810097290A patent/CN101269113B/zh active Active
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101849630A (zh) * | 2010-06-25 | 2010-10-06 | 延边大学 | 黄芪保健食品及其制备方法 |
CN101849630B (zh) * | 2010-06-25 | 2013-01-02 | 延边大学 | 黄芪保健食品及其制备方法 |
CN103105371A (zh) * | 2011-11-10 | 2013-05-15 | 长白山制药股份有限公司 | 一种药物组合物注射液的质量检测方法 |
CN103105371B (zh) * | 2011-11-10 | 2015-03-18 | 长白山制药股份有限公司 | 一种药物组合物注射液的质量检测方法 |
CN103575667A (zh) * | 2012-07-24 | 2014-02-12 | 长白山制药股份有限公司 | 一种药物组合物注射液总皂苷的含量测定方法 |
CN103575667B (zh) * | 2012-07-24 | 2016-03-23 | 长白山制药股份有限公司 | 一种药物组合物注射液总皂苷的含量测定方法 |
CN103977060A (zh) * | 2014-05-16 | 2014-08-13 | 长白山制药股份有限公司 | 一种抗肿瘤药物组合物及其制备方法 |
CN103977060B (zh) * | 2014-05-16 | 2017-02-08 | 长白山制药股份有限公司 | 一种抗肿瘤药物组合物及其制备方法 |
CN107625894A (zh) * | 2017-10-12 | 2018-01-26 | 吉林化工学院 | 一种复方参芪分散片的制备方法 |
CN111686148A (zh) * | 2019-11-06 | 2020-09-22 | 成都青之欣生物科技有限公司 | 抗衰老的中药提取物及其提取方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN101269113B (zh) | 2012-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101036774B (zh) | 一种复方斑蝥口服制剂的检测方法 | |
CN101167788B (zh) | 一种用于久病虚损,气阴不足的贞芪扶正中药制剂质控方法 | |
CN106370749A (zh) | 一种人参固本口服液的质量检测方法 | |
CN101269113B (zh) | 一种治疗肿瘤的药物组合物的质量检测方法 | |
CN100402053C (zh) | 一种中药制剂的质量控制方法 | |
CN102145041B (zh) | 一种具有治疗多囊卵巢综合症作用的药物组合物 | |
CN101011527B (zh) | 一种橘红丸的改型制剂及其制备方法 | |
CN101708208B (zh) | 治疗关节肿痛的胶囊制剂的检测方法 | |
CN101966223A (zh) | 一种复方扶芳藤制剂的指纹图谱检测方法 | |
CN102614378A (zh) | 养阴降糖中药组合物及其制备方法和检测方法 | |
CN102579734B (zh) | 骨愈灵中药组合物及其制备方法和检测方法 | |
CN106290599B (zh) | 一种中药组合物的含量测定方法 | |
CN103285306A (zh) | 益气补肾的中药组合物的制备方法及检测方法 | |
CN103344737A (zh) | 一种治疗鼻窦炎的中药片剂的质量控制方法 | |
CN1895438B (zh) | 一种治疗头痛的中药组合物及其制备方法 | |
CN100408051C (zh) | 一种中药组合物的质量控制方法 | |
CN100594034C (zh) | 治疗糖尿病的降糖甲制剂及其制备方法和检测方法 | |
CN102218122A (zh) | 一种海龙蛤蚧口服液的质量控制检测方法 | |
CN102091297A (zh) | 一种肝保健药品的质量控制方法 | |
CN104483435A (zh) | 一种天麻灵芝颗粒的检测方法 | |
CN101066437B (zh) | 一种复方斑蝥口服制剂的检测方法 | |
CN101391070B (zh) | 一种具有抗癌作用的中药组合物的检测方法 | |
CN1857445B (zh) | 一种得生制剂的检测方法 | |
CN101879271B (zh) | 橘红胶囊的质量检测方法 | |
CN101780190B (zh) | 一种含龙血竭提取物的药物制剂的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20080924 Assignee: CHANGBAISHAN PHARMACEUTICAL Co.,Ltd. Assignor: Li Yanqun Contract record no.: 2014220000026 Denomination of invention: Quality control method for medicament composition for treating knubble Granted publication date: 20120829 License type: Exclusive License Record date: 20140529 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: CHANGBAISHAN PHARMACEUTICAL Co.,Ltd. Assignor: Li Yanqun Contract record no.: 2014220000026 Date of cancellation: 20140708 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20080924 Assignee: CHANGBAISHAN PHARMACEUTICAL Co.,Ltd. Assignor: Li Yanqun Contract record no.: 2014220000036 Denomination of invention: Quality control method for medicament composition for treating knubble Granted publication date: 20120829 License type: Exclusive License Record date: 20140715 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191230 Address after: 132000 3-1-17, purple garden, camp, Jilin, Jilin Patentee after: Li Dongxuan Address before: 132013 No. 103, Shenzhen street, hi tech Zone, Jilin, Jilin Patentee before: Li Yanqun |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221123 Address after: 132500 No.43, West Chang'an Road, Minzhu street, Jiaohe City, Jilin Province Patentee after: CHANGBAISHAN PHARMACEUTICAL Co.,Ltd. Address before: 132000 no.3-1-17 Ziguang garden, Chuanying District, Jilin City, Jilin Province Patentee before: Li Dongxuan |